AM.perfusion SRL
AM.perfusion reported total assets of 133,454 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of AM.perfusion shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +19 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AM.perfusion's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −27,039 € | ||||
| Equity | −23,525 € | ||||
| Cash | 58,439 € | ||||
| EBITDA | 45,676 € | ||||
| Total assets | 133,454 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
AM.perfusion's financial analysis
- Solvency-17.6%sector median: 62.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AM.perfusion
AM.perfusion's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0771.319.749
- VAT number
- BE0771319749
- Peppol
- Registered · 0208:0771319749 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jul 2021
- Registered office
- 4317 Faimes
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Nursing and midwifery activities (NACE 86940)
AM.perfusion (SRL) has been based in Faimes since 2021, active in: nursing and midwifery activities. For 2025, it reports a net loss of 27,039 € and equity of −23,525 €; its revenue is not published. Its solvency stands at -17.6%, below the median of its sector (62.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to AM.perfusion
Companies in the same business, of comparable size and area, outside its group.
- Place L.P. Oupeye · balance sheet 133,441 €
- Nkwy Life Science Consulting Computing infrastructure, data processing, hosting and related activities Berchem-Sainte-Agathe · balance sheet 133,391 €
- Mafika Sawmilling and planing of wood Fernelmont · balance sheet 133,520 €
- NMTH Tournai · balance sheet 133,416 €
- Docteur Robert Gvozdenovic SPRL Seraing · balance sheet 133,375 €
Frequently asked questions about AM.perfusion
What is the revenue of AM.perfusion?
AM.perfusion files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AM.perfusion?
In Belgium, the VAT number is the company number prefixed with BE: BE0771319749 for AM.perfusion, if the company is VAT-registered. Its company number (CBE) is 0771.319.749.
Where is the registered office of AM.perfusion?
According to the CBE register, the registered office of AM.perfusion is in 4317 Faimes.
What is the equity of AM.perfusion?
At the close of the 2025 financial year, the equity of AM.perfusion amounts to -23,525 €, a solvency of -17.6% of total assets.
Who manages AM.perfusion?
The register lists 2 active mandates at AM.perfusion. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AM.perfusion
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →